Global Next Generation Sequencing Technology Market Research Report 2024
Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical
Publisher : MRA | Format : PDF
Global Next Generation Sequencing Technology Market Research Report 2024
Next Generation Sequencing (NGS) is a high-throughput method for rapid sequencing of base pairs of DNA or RNA samples. Next generation sequencing systems can be divided by three parts, instruments, consumables and related services. At the same time, NGS also supports a wide range of applications, including gene expression profiling, chromosome counting, epigenetic change detection, and molecular analysis, which can drive discovery research and realize the bright future of personalized medicine.
According to MRAResearch’s new survey, global Next Generation Sequencing Technology market is projected to reach US$ 12360 million in 2033, increasing from US$ 4486 million in 2022, with the CAGR of 15.4% during the period of 2023 to 2033. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Next Generation Sequencing Technology market research.
The Next Generation Sequencing (NGS) Technology market is driven by the increasing demand for personalized medicine and advancements in genomic research. NGS technology enables rapid and high-throughput DNA and RNA sequencing, offering insights into genetic variations and molecular profiles for various applications in healthcare and life sciences. The rise in genetic diseases and cancer cases contributes to market growth as researchers and clinicians seek comprehensive genetic information for diagnosis, treatment, and drug development. Moreover, technological innovations in sequencing platforms and data analysis align with improved accuracy, speed, and cost-effectiveness of sequencing processes. However, the market also faces challenges, including managing and interpreting large volumes of genomic data and addressing ethical and privacy concerns related to genetic information. Additionally, ensuring standardization and quality control in NGS workflows and navigating regulatory requirements can pose obstacles for stakeholders. To succeed, companies must focus on data analytics solutions, collaborations in multi-omics research, and addressing the challenges to meet the increasing demand for NGS technology that drives advancements in personalized medicine and genomics research.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Next Generation Sequencing Technology market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Eurofins Scientific
Natera
BGI
Illumina
Roche
LabCorp
Berry Genomics
Brooks Life Sciences
Macrogen
Personalis
Novogene
Genotypic Technology
Dna Link
Segment by Type
Targeted Sequencing
Whole Exome Sequencing
Whole Genome Sequencing
Hospitals and Clinics
Biopharma Companies
Academic & Research Organizations
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Next Generation Sequencing Technology report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source
According to MRAResearch’s new survey, global Next Generation Sequencing Technology market is projected to reach US$ 12360 million in 2033, increasing from US$ 4486 million in 2022, with the CAGR of 15.4% during the period of 2023 to 2033. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Next Generation Sequencing Technology market research.
The Next Generation Sequencing (NGS) Technology market is driven by the increasing demand for personalized medicine and advancements in genomic research. NGS technology enables rapid and high-throughput DNA and RNA sequencing, offering insights into genetic variations and molecular profiles for various applications in healthcare and life sciences. The rise in genetic diseases and cancer cases contributes to market growth as researchers and clinicians seek comprehensive genetic information for diagnosis, treatment, and drug development. Moreover, technological innovations in sequencing platforms and data analysis align with improved accuracy, speed, and cost-effectiveness of sequencing processes. However, the market also faces challenges, including managing and interpreting large volumes of genomic data and addressing ethical and privacy concerns related to genetic information. Additionally, ensuring standardization and quality control in NGS workflows and navigating regulatory requirements can pose obstacles for stakeholders. To succeed, companies must focus on data analytics solutions, collaborations in multi-omics research, and addressing the challenges to meet the increasing demand for NGS technology that drives advancements in personalized medicine and genomics research.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Next Generation Sequencing Technology market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Eurofins Scientific
Natera
BGI
Illumina
Roche
LabCorp
Berry Genomics
Brooks Life Sciences
Macrogen
Personalis
Novogene
Genotypic Technology
Dna Link
Segment by Type
Targeted Sequencing
Whole Exome Sequencing
Whole Genome Sequencing
Segment by Application
Hospitals and Clinics
Biopharma Companies
Academic & Research Organizations
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Next Generation Sequencing Technology report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source